Scar

Manufacturer
CVS | Product Quest Mdf
Effective date
2018-04-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:56:36

Label at a glance#

ProductScar CVS
Active ingredientAllantoin
Label structure10 sections

Label contents#

Full prescribing information#

Active ingredient                   Purpose

OTC - ACTIVE INGREDIENT SECTION

Allantoin 0.5%........................Skin Protectant

INDICATIONS & USAGE SECTION

Uses temporarily protects and helps relieve chapped or cracked skin

OTC - WHEN USING SECTION

When using this product • do not get into eyes

OTC - STOP USE SECTION

Stop use and ask a doctor if • condition worsens • symptoms persist for more than 7 days or clear up and occur again within a few days

OTC - DO NOT USE SECTION

Do not use on • deep puncture wounds • animal bites • serious burns

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed,get medical help or contact a Poison Control Center immediately

DOSAGE & ADMINISTRATION SECTION

Directions • Apply as needed

INACTIVE INGREDIENT SECTION

Inactive ingredients
Water, Glycerin, Glyceryl Acrylate/Acrylic Acid
Copolymer, Propylene Glycol, Allium Cepa
(Onion) Root Extract, Polysorbate 20, Sorbitol,
Lecithin, Xanthan Gum, Oleic Acid,
Beta-Glucan, Sodium Carbomer, Aloe
Barbadensis Leaf Extract, Juglans Regia
(Walnut) Seed Extract, Chamomilla Recutita
(Matricaria) Flower Extract, Fragrance,
Caprylyl Glycol, 1,2-Hexanediol,
Ethylhexylglycerin, Phenoxyethanol, Disodium
EDTA, Phytonadione.

OTHER SAFETY INFORMATION

Other information Store at room temperature

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1442087allantoin 0.5 % Topical GelPSN1
1442087allantoin 0.005 MG/MG Topical GelSCD1
1442087allantoin 0.5 % Topical GelSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
16a2c1cd-ae95-d910-f03d-7e06b11dd243Product name520260202
653485de-0601-41e4-82db-7a60bb223e27Product name120251024
23fb3cda-2b50-f3d3-ebde-f542350bd77bProduct name420240828
081b54f0-4545-48b6-b854-03e1401f09eaProduct name120230112
aead65a2-216e-4ff8-a178-44aab77c24edProduct name120180531

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69842-668-022020-01-31C16284748780-19d75b9d0-aa5c-f424-e053-dadaa90a57ceWalgreens Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69842-668-02ScarCVS1 in 1 CARTONGEL11
69842-668-02ScarCVS20 g in 1 TUBEGEL201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69842-668SCAR CVS (ALLANTOIN 0.5%) GEL [CVS]1Legacy NDC, 2 package rows20180815_4d59d0dc-9f3c-4eb8-b7e6-4a8dce405805.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69842-66869842-668-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e1453e54-7d36-4701-bfb2-503454f1e7c24d59d0dc-9f3c-4eb8-b7e6-4a8dce4058052018-04-26WarningsExact identifier
spl id: e1453e54-7d36-4701-bfb2-503454f1e7c2
spl set id: 4d59d0dc-9f3c-4eb8-b7e6-4a8dce405805

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.